Post-earnings recap
Reported
Mon, Jan 23, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ResMed's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock's slight decline suggests that investors may have been looking for more comprehensive revenue details or guidance. The lack of revenue numbers and guidance could lead to uncertainty among investors moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.73 | N/A | +4.89% |
| Revenue | N/A | N/A | N/A |
Management expressed cautious optimism about future demand for their products. They acknowledged some supply chain challenges but are focused on innovation.
Management highlighted ongoing demand for sleep apnea products.
They noted challenges in the global supply chain but remain focused on innovation.
The team emphasized their commitment to long-term growth despite short-term hurdles.